ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.070
-0.010 (-0.93%)
At close: Apr 28, 2026, 4:00 PM EDT
1.070
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $26.44 million as of April 28, 2026. Its market cap has increased by 94.41% in one year.
Market Cap
26.44M
Enterprise Value
29.41M
1-Year Change
94.41%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $26.44M, a decrease of -66.74%. That is a compound annual growth rate of -20.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 27.50M | -46.91% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 28.09M |
| Polyrizon | 27.74M |
| Lantern Pharma | 27.57M |
| Longeveron | 27.52M |
| NanoViricides | 27.21M |
| Neuphoria Therapeutics | 27.17M |
| AEON Biopharma | 26.57M |
| NeuroSense Therapeutics | 26.52M |